{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:54:56Z","timestamp":1790067296988,"version":"4.0.1"},"reference-count":63,"publisher":"Radiation Research Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1667\/rr0968.1","type":"journal-article","created":{"date-parts":[[2007,11,28]],"date-time":"2007-11-28T15:31:18Z","timestamp":1196263878000},"page":"639-649","source":"Crossref","is-referenced-by-count":49,"title":["A Radiation-Induced Gene Signature Distinguishes Post-Chernobyl from Sporadic Papillary Thyroid Cancers"],"prefix":"10.1667","volume":"168","author":[{"given":"M.","family":"Port","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Boltze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"R\u00f6per","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Meineke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1243","reference":[{"key":"i0033-7587-168-6-639-b1","doi-asserted-by":"crossref","unstructured":"Feinmesser, R., E. Lubin, K. Segal, and A. Noyek. Carcinoma of the thyroid in children\u2014a review. J. Pediatr. Endocrinol. Metab 10:561\u2013568.1997.","DOI":"10.1515\/JPEM.1997.10.6.561"},{"key":"i0033-7587-168-6-639-b2","doi-asserted-by":"crossref","unstructured":"Collins, B. J., A. B. Schneider, R. A. Prinz, and X. Xu. Low frequency of BRAF mutations in adult patients with papillary thyroid cancers following childhood radiation exposure. Thyroid 16:61\u201366.2006.","DOI":"10.1089\/thy.2006.16.61"},{"key":"i0033-7587-168-6-639-b3","doi-asserted-by":"crossref","unstructured":"Blackburn, D. J., L. A. Michel, A. Rosiere, J. P. Trigaux, and J. E. Donckier. Occurrence of thyroid papillary carcinoma in young patients. A Chernobyl connection? J. Pediatr. Endocrinol. Metab 14:503\u2013506.2001.","DOI":"10.1515\/JPEM.2001.14.5.503"},{"key":"i0033-7587-168-6-639-b4","doi-asserted-by":"crossref","unstructured":"Schlumberger, M., A. F. Cailleux, H. G. Suarez, and F. de Vathaire. Irradiation and second cancers. The thyroid as a case in point. C. R. Acad. Sci. III 322:205\u2013213.1999.","DOI":"10.1016\/S0764-4469(99)80045-6"},{"key":"i0033-7587-168-6-639-b5","unstructured":"Wiersinga, W. M. Thyroid cancer in children and adolescents\u2014consequences in later life. J. Pediatr. Endocrinol. Metab 14:(Suppl. 5), 1289\u20131298.2001."},{"key":"i0033-7587-168-6-639-b6","doi-asserted-by":"crossref","unstructured":"Pacini, F., T. Vorontsova, E. Molinaro, E. Shavrova, L. Agate, E. Kuchinskaya, R. Elisei, E. P. Demidchik, and A. Pinchera. Thyroid consequences of the Chernobyl nuclear accident. Acta Paediatr. Suppl 88:23\u201327.1999.","DOI":"10.1111\/j.1651-2227.1999.tb14399.x"},{"key":"i0033-7587-168-6-639-b7","doi-asserted-by":"crossref","unstructured":"Williams, E. D., A. Abrosimov, T. Bogdanova, E. P. Demidchik, M. Ito, V. LiVolsi, E. Lushnikov, J. Rosai, Y. Sidorov, and G. A. Thomas. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br. J. Cancer 90:2219\u20132224.2004.","DOI":"10.1038\/sj.bjc.6601860"},{"key":"i0033-7587-168-6-639-b8","doi-asserted-by":"crossref","unstructured":"Rybakov, S. J., I. V. Komissarenko, N. D. Tronko, A. N. Kvachenyuk, T. I. Bogdanova, A. E. Kovalenko, and M. Y. Bolgov. Thyroid cancer in children of Ukraine after the Chernobyl accident. World J. Surg 24:1446\u20131449.2000.","DOI":"10.1007\/s002680010239"},{"key":"i0033-7587-168-6-639-b9","doi-asserted-by":"crossref","unstructured":"Ito, M., S. Yamashita, K. Ashizawa, H. Namba, M. Hoshi, Y. Shibata, I. Sekine, S. Nagataki, and I. Shigematsu. Childhood thyroid diseases around Chernobyl evaluated by ultrasound examination and fine needle aspiration cytology. Thyroid 5:365\u2013368.1995.","DOI":"10.1089\/thy.1995.5.365"},{"key":"i0033-7587-168-6-639-b10","doi-asserted-by":"crossref","unstructured":"Nikiforov, Y. E., C. S. Heffess, A. V. Korzenko, J. A. Fagin, and D. R. Gnepp. Characteristics of follicular tumors and nonneoplastic thyroid lesions in children and adolescents exposed to radiation as a result of the Chernobyl disaster. Cancer 76:900\u2013909.1995.","DOI":"10.1002\/1097-0142(19950901)76:5<900::AID-CNCR2820760527>3.0.CO;2-X"},{"key":"i0033-7587-168-6-639-b11","doi-asserted-by":"crossref","unstructured":"Tronko, M. D., T. I. Bogdanova, I. V. Komissarenko, O. V. Epstein, V. Oliynyk, A. Kovalenko, I. A. Likhtarev, I. Kairo, S. B. Peters, and V. A. LiVolsi. Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics. Cancer 86:149\u2013156.1999.","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<149::AID-CNCR21>3.0.CO;2-A"},{"key":"i0033-7587-168-6-639-b12","doi-asserted-by":"crossref","unstructured":"Shirahige, Y., M. Ito, K. Ashizawa, T. Motomura, N. Yokoyama, H. Namba, S. Fukata, T. Yokozawa, N. Ishikawa, and S. Nagataki. Childhood thyroid cancer: comparison of Japan and Belarus. Endocr. J 45:203\u2013209.1998.","DOI":"10.1507\/endocrj.45.203"},{"key":"i0033-7587-168-6-639-b13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940715)74:2<748::AID-CNCR2820740231>3.0.CO;2-H"},{"key":"i0033-7587-168-6-639-b14","doi-asserted-by":"crossref","unstructured":"Leenhardt, L., P. Grosclaude, and L. Cherie-Challine. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056\u20131060.2004.","DOI":"10.1089\/thy.2004.14.1056"},{"key":"i0033-7587-168-6-639-b15","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00449-4"},{"key":"i0033-7587-168-6-639-b16","doi-asserted-by":"publisher","DOI":"10.1007\/BF01309218"},{"key":"i0033-7587-168-6-639-b17","doi-asserted-by":"crossref","unstructured":"Jaworowski, Z. Editorial: Chernobyl proportions. Environ. Int 14:69\u201373.1988.","DOI":"10.1016\/0160-4120(88)90082-7"},{"key":"i0033-7587-168-6-639-b18","doi-asserted-by":"crossref","unstructured":"Shaha, A. R. TNM classification of thyroid carcinoma. World J. Surg 31:879\u2013887.2007.","DOI":"10.1007\/s00268-006-0864-0"},{"key":"i0033-7587-168-6-639-b19","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2004.11.001"},{"key":"i0033-7587-168-6-639-b20","doi-asserted-by":"crossref","unstructured":"Seidl, C., M. Port, K. P. Gilbertz, A. Morgenstern, F. Bruchertseifer, M. Schwaiger, B. R\u00f6per, R. Senekowitsch-Schmidtke, and M. Abend.213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2arrest and up-regulation of genes known to prevent apoptosis but induced necrosis and mitotic catastrophe. Mol. Cancer Ther 6:2346\u20132359.2007.","DOI":"10.1158\/1535-7163.MCT-07-0132"},{"key":"i0033-7587-168-6-639-b21","unstructured":"Maenhaut, C. Gene expression profiling in human thyroid tumors. Bull. Mem. Acad. R. Med. Belg 159:533\u2013539.2004."},{"key":"i0033-7587-168-6-639-b22","doi-asserted-by":"crossref","unstructured":"Takahashi, M. Oncogenic activation of the ret protooncogene in thyroid cancer. Crit. Rev. Oncog 6:35\u201346.1995.","DOI":"10.1615\/CritRevOncog.v6.i1.30"},{"key":"i0033-7587-168-6-639-b23","doi-asserted-by":"crossref","unstructured":"Ciampi, R., J. A. Knauf, R. Kerler, M. Gandhi, Z. Zhu, M. N. Nikiforova, H. M. Rabes, J. A. Fagin, and Y. E. Nikiforov. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J. Clin. Invest 115:94\u2013101.2005.","DOI":"10.1172\/JCI200523237"},{"key":"i0033-7587-168-6-639-b24","doi-asserted-by":"crossref","unstructured":"Detours, V., S. Wattel, D. Venet, N. Hutsebaut, T. Bogdanova, M. D. Tronko, J. E. Dumont, B. Franc, G. Thomas, and C. Maenhaut. Absence of a specific radiation signature in post-Chernobyl thyroid cancers. Br. J. Cancer 92:1545\u20131552.2005.","DOI":"10.1038\/sj.bjc.6602521"},{"key":"i0033-7587-168-6-639-b25","doi-asserted-by":"crossref","unstructured":"Unger, K., H. Zitzelsberger, G. Salvatore, M. Santoro, T. Bogdanova, H. Braselmann, P. Kastner, L. Zurnadzhy, N. Tronko, and G. Thomas. Heterogeneity in the distribution of RET\/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J. Clin. Endocrinol. Metab 89:4272\u20134279.2004.","DOI":"10.1210\/jc.2003-031870"},{"key":"i0033-7587-168-6-639-b26","doi-asserted-by":"crossref","unstructured":"Rabes, H. M. Gene rearrangements in radiation-induced thyroid carcinogenesis. Med. Pediatr. Oncol 36:574\u2013582.2001.","DOI":"10.1002\/mpo.1133"},{"key":"i0033-7587-168-6-639-b27","doi-asserted-by":"crossref","unstructured":"Richter, H., H. Braselmann, L. Hieber, G. Thomas, T. Bogdanova, N. Tronko, and H. Zitzelsberger. Chromosomal imbalances in post-Chernobyl thyroid tumors. Thyroid 14:1061\u20131064.2004.","DOI":"10.1089\/thy.2004.14.1061"},{"key":"i0033-7587-168-6-639-b28","doi-asserted-by":"crossref","unstructured":"Kimmel, R. R., L. P. Zhao, D. Nguyen, S. Lee, M. Aronszajn, C. Cheng, V. P. Troshin, A. Abrosimov, J. Delrow, and P. E. Neiman. Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer. Radiat. Res 166:519\u2013531.2006.","DOI":"10.1667\/RR0547.1"},{"key":"i0033-7587-168-6-639-b29","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-004-1070-9"},{"key":"i0033-7587-168-6-639-b30","doi-asserted-by":"crossref","unstructured":"Ito, M., M. Nakashima, T. Nakayama, A. Ohtsuru, Y. Nagayama, N. Takamura, E. P. Demedchik, I. Sekine, and S. Yamashita. Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around Chernobyl. Thyroid 12:971\u2013975.2002.","DOI":"10.1089\/105072502320908303"},{"key":"i0033-7587-168-6-639-b31","doi-asserted-by":"crossref","unstructured":"Mizukami, Y., A. Nonomura, T. Hashimoto, S. Terahata, F. Matsubara, T. Michigishi, and M. Noguchi. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues. Cancer 61:873\u2013880.1988.","DOI":"10.1002\/1097-0142(19880301)61:5<873::AID-CNCR2820610504>3.0.CO;2-W"},{"key":"i0033-7587-168-6-639-b32","doi-asserted-by":"crossref","unstructured":"Szkanderova, S., M. Port, J. Stulik, L. Hernychova, I. Kasalova, D. Van Beuningen, and M. Abend. Comparison of the abundance of 10 radiation-induced proteins with their differential gene expression in L929 cells. Int. J. Radiat. Biol 79:623\u2013633.2003.","DOI":"10.1080\/09553000310001606821"},{"key":"i0033-7587-168-6-639-b33","unstructured":"Waldmann, V. and H. M. Rabes. Absence of G(s)alpha gene mutations in childhood thyroid tumors after Chernobyl in contrast to sporadic adult thyroid neoplasia. Cancer Res 57:2358\u20132361.1997."},{"key":"i0033-7587-168-6-639-b34","doi-asserted-by":"crossref","unstructured":"Fukushima, T., S. Suzuki, M. Mashiko, T. Ohtake, Y. Endo, Y. Takebayashi, K. Sekikawa, K. Hagiwara, and S. Takenoshita. BRAF mutations in papillary carcinomas of the thyroid. Oncogene 22:6455\u20136457.2003.","DOI":"10.1038\/sj.onc.1206739"},{"key":"i0033-7587-168-6-639-b35","unstructured":"Lu, Z. H., G. C. Luo, J. M. Lu, and C. Y. Pan. The expression of G proteins alpha-subunit mRNA in different thyroid diseases. Zhonghua Nei Ke. Za Zhi 42:103\u2013105.2003."},{"key":"i0033-7587-168-6-639-b36","doi-asserted-by":"crossref","unstructured":"Scarpino, S., F. C. D'Alena, A. Di Napoli, F. Ballarini, M. Prat, and L. P. Ruco. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. J. Pathol 199:243\u2013250.2003.","DOI":"10.1002\/path.1278"},{"key":"i0033-7587-168-6-639-b37","doi-asserted-by":"crossref","unstructured":"Song, B. Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases. Acta Pathol. Jpn 41:336\u2013343.1991.","DOI":"10.1111\/j.1440-1827.1991.tb01656.x"},{"key":"i0033-7587-168-6-639-b38","doi-asserted-by":"crossref","unstructured":"Yano, Y., N. Uematsu, T. Yashiro, H. Hara, E. Ueno, M. Miwa, G. Tsujimoto, Y. Aiyoshi, and K. Uchida. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma. Clin. Cancer Res 10:2035\u20132043.2004.","DOI":"10.1158\/1078-0432.CCR-0807-03"},{"key":"i0033-7587-168-6-639-b39","doi-asserted-by":"crossref","unstructured":"Pasieka, Z., H. Stepien, J. Komorowski, K. Kolomecki, and K. Kuzdak. Evaluation of the levels of bFGF, VEGF, sICAM-1, and sVCAM-1 in serum of patients with thyroid cancer. Recent Results Cancer Res 162:189\u2013194.2003.","DOI":"10.1007\/978-3-642-59349-9_18"},{"key":"i0033-7587-168-6-639-b40","doi-asserted-by":"crossref","unstructured":"Yu, X. M., C. Y. Lo, W. F. Chan, K. Y. Lam, P. Leung, and J. M. Luk. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Clin. Cancer Res 11:8063\u20138069.2005.","DOI":"10.1158\/1078-0432.CCR-05-0646"},{"key":"i0033-7587-168-6-639-b41","doi-asserted-by":"crossref","unstructured":"Siironen, P., J. Louhimo, S. Nordling, A. Ristimaki, H. Maenpaa, R. Haapiainen, and C. Haglund. Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumour Biol 26:57\u201364.2005.","DOI":"10.1159\/000085586"},{"key":"i0033-7587-168-6-639-b42","doi-asserted-by":"crossref","unstructured":"Fuhrer, D., M. Eszlinger, S. Karger, K. Krause, C. Engelhardt, D. Hasenclever, H. Dralle, and R. Paschke. Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours. Eur. J. Endocrinol 152:785\u2013790.2005.","DOI":"10.1530\/eje.1.01912"},{"key":"i0033-7587-168-6-639-b43","doi-asserted-by":"crossref","unstructured":"Lo, C. Y., K. Y. Lam, P. P. Leung, and J. M. Luk. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma. Eur. J. Endocrinol 152:545\u2013550.2005.","DOI":"10.1530\/eje.1.01883"},{"key":"i0033-7587-168-6-639-b44","doi-asserted-by":"crossref","unstructured":"Weber, K. B., K. R. Shroyer, D. E. Heinz, S. Nawaz, M. S. Said, and B. R. Haugen. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer. Am. J. Clin. Pathol 122:524\u2013531.2004.","DOI":"10.1309\/UUQTE505PTN5QJ7M"},{"key":"i0033-7587-168-6-639-b45","doi-asserted-by":"crossref","unstructured":"Iwase, K., A. Nagasaka, K. Kato, S. Ohtani, T. Tsujimura, A. Inagaki, S. Jimbo, A. Nakai, R. Masunaga, and M. Hamada. Localization of Cu\/Zn and Mn superoxide dismutase in various thyroid disorders. Acta Endocrinol. (Copenh.) 129:573\u2013578.1993.","DOI":"10.1530\/acta.0.1290573"},{"key":"i0033-7587-168-6-639-b46","doi-asserted-by":"crossref","unstructured":"Siironen, P., A. Ristimaki, S. Nordling, J. Louhimo, R. Haapiainen, and C. Haglund. Expression of COX-2 is increased with age in papillary thyroid cancer. Histopathology 44:490\u2013497.2004.","DOI":"10.1111\/j.1365-2559.2004.01880"},{"key":"i0033-7587-168-6-639-b47","unstructured":"Mardente, S., L. Lenti, E. Lococo, F. Consorti, R. C. Della, S. Romeo, R. Misasi, and A. Antonaci. Phenotypic and functional characterization of lymphocytes in autoimmune thyroiditis and in papillary carcinoma. Anticancer Res 25:2483\u20132488.2005."},{"key":"i0033-7587-168-6-639-b48","doi-asserted-by":"crossref","unstructured":"Van Jr., S. H., S. M. Hughes, C. Bower, and D. M. Parham. Lymphocytic infiltration in pediatric thyroid carcinomas. Pediatr. Dev. Pathol 7:487\u2013492.2004.","DOI":"10.1007\/s10024-003-3028-3"},{"key":"i0033-7587-168-6-639-b49","doi-asserted-by":"crossref","unstructured":"Modi, J., A. Patel, R. Terrell, R. M. Tuttle, and G. L. Francis. Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes. J. Clin. Endocrinol. Metab 88:4418\u20134425.2003.","DOI":"10.1210\/jc.2003-030342"},{"key":"i0033-7587-168-6-639-b50","doi-asserted-by":"crossref","unstructured":"Lindhorst, E., P. M. Schumm-Draeger, J. Bojunga, K. H. Usadel, and G. Herrmann. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma. Exp. Clin. Endocrinol. Diabetes 110:27\u201331.2002.","DOI":"10.1055\/s-2002-19991"},{"key":"i0033-7587-168-6-639-b51","doi-asserted-by":"crossref","unstructured":"Gupta, S., A. Patel, A. Folstad, C. Fenton, C. A. Dinauer, R. M. Tuttle, R. Conran, and G. L. Francis. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J. Clin. Endocrinol. Metab 86:1346\u20131354.2001.","DOI":"10.1210\/jcem.86.3.7310"},{"key":"i0033-7587-168-6-639-b52","doi-asserted-by":"crossref","unstructured":"Matsubayashi, S., K. Kawai, Y. Matsumoto, T. Mukuta, T. Morita, K. Hirai, F. Matsuzuka, K. Kakudoh, K. Kuma, and H. Tamai. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J. Clin. Endocrinol. Metab 80:3421\u20133424.1995.","DOI":"10.1210\/jcem.80.12.8530576"},{"key":"i0033-7587-168-6-639-b53","doi-asserted-by":"crossref","unstructured":"Jarzab, B., M. Wiench, K. Fujarewicz, K. Simek, M. Jarzab, M. Oczko-Wojciechowska, J. Wloch, A. Czarniecka, E. Chmielik, and A. Swierniak. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res 65:1587\u20131597.2005.","DOI":"10.1158\/0008-5472.CAN-04-3078"},{"key":"i0033-7587-168-6-639-b54","doi-asserted-by":"crossref","unstructured":"Kameyama, K. Expression of MMP-1 in the capsule of thyroid cancer\u2014relationship with invasiveness. Pathol. Res. Pract 192:20\u201326.1996.","DOI":"10.1016\/S0344-0338(96)80125-7"},{"key":"i0033-7587-168-6-639-b55","doi-asserted-by":"crossref","unstructured":"Korem, S., M. B. Resnick, and Z. Kraiem. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells. J. Clin. Endocrinol. Metab 84:3322\u20133327.1999.","DOI":"10.1210\/jc.84.9.3322"},{"key":"i0033-7587-168-6-639-b56","doi-asserted-by":"crossref","unstructured":"Patel, A., A. M. Straight, H. Mann, E. Duffy, C. Fenton, C. Dinauer, R. M. Tuttle, and G. L. Francis. Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents. J. Endocrinol. Invest 25:403\u2013408.2002.","DOI":"10.1007\/BF03344028"},{"key":"i0033-7587-168-6-639-b57","doi-asserted-by":"crossref","unstructured":"Lin, S. Y., Y. Y. Wang, and W. H. Sheu. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer. Clin. Endocrinol. (Oxf.) 58:513\u2013518.2003.","DOI":"10.1046\/j.1365-2265.2003.01749.x"},{"key":"i0033-7587-168-6-639-b58","doi-asserted-by":"crossref","unstructured":"Hall, P. Radiation-induced thyroid cancer. Med. Oncol. Tumor Pharmacother 9:183\u2013189.1992.","DOI":"10.1007\/BF02987755"},{"key":"i0033-7587-168-6-639-b59","doi-asserted-by":"crossref","unstructured":"Williams, E. D., F. Pacini, and A. Pinchera. Thyroid cancer following Chernobyl. J. Endocrinol. Invest 18:144\u2013146.1995.","DOI":"10.1007\/BF03349725"},{"key":"i0033-7587-168-6-639-b60","doi-asserted-by":"crossref","unstructured":"Boltze, C., G. Brabant, H. Dralle, R. Gerlach, A. Roessner, and C. Hoang-Vu. Radiation-induced thyroid carcinogenesis as a function of time and dietary iodine supply: anin vivomodel of tumorigenesis in the rat. Endocrinology 143:2584\u20132592.2002.","DOI":"10.1210\/endo.143.7.8914"},{"key":"i0033-7587-168-6-639-b61","doi-asserted-by":"crossref","unstructured":"Fukui, T., M. Kondo, G. Ito, O. Maeda, N. Sato, H. Yoshioka, K. Yokoi, Y. Ueda, K. Shimokata, and Y. Sekido. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene 24:6323\u20136327.2005.","DOI":"10.1038\/sj.onc.1208777"},{"key":"i0033-7587-168-6-639-b62","doi-asserted-by":"crossref","unstructured":"Ko, J., K. S. Ryu, Y. H. Lee, D. S. Na, Y. S. Kim, Y. M. Oh, I. S. Kim, and J. W. Kim. Human secreted frizzled-related protein is down-regulated and induces apoptosis in human cervical cancer. Exp. Cell Res 280:280\u2013287.2002.","DOI":"10.1006\/excr.2002.5649"},{"key":"i0033-7587-168-6-639-b63","doi-asserted-by":"crossref","unstructured":"Liu, T. H., A. Raval, S. S. Chen, J. J. Matkovic, J. C. Byrd, and C. Plass. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res 66:653\u2013658.2006.","DOI":"10.1158\/0008-5472.CAN-05-3712"}],"container-title":["Radiation Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:18:39Z","timestamp":1684109919000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.bioone.org\/doi\/10.1667\/RR0968.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1667\/RR0968.1"],"URL":"https:\/\/doi.org\/10.1667\/rr0968.1","relation":{},"ISSN":["0033-7587","1938-5404"],"issn-type":[{"value":"0033-7587","type":"print"},{"value":"1938-5404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}